Business Wire News Releases | High River Times
Tilray Board of Directors Announces Approval of Amendment to Company's Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
NANAIMO, British Columbia — Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced that the Tilray board of directors approved an amendment to the Company’s bylaws to reduce the quorum requirement for shareholder meetings from shareholders representing a majority of the voting power of the outstanding shares entitled to vote to one-third of the voting power of the outstanding shares entitled to vote.
BPLI Holdings Inc. Completes Going-Private Transaction
ST. JOHN’S, Newfoundland and Labrador — BPLI Holdings Inc. (“ BPLI ” or the “ Company “) (TSXV: BPLI) announced today that, pursuant to the previously announced plan of arrangement under the Canada Business Corporations Act (the “ Arrangement “), Rizbollo Holdings Limited (“ Rizbollo ”) and Name 3 Capital Inc. (“ Name 3 ”), acting through a wholly-owned subsidiary, 12491125 Canada Inc. (“ Acquisitionco ”), have indirectly acquired all of the issued and outstanding common shares of BPLI (“ Shares “) effective today at a price of C$0.23 per Share other than certain Shares beneficially owned or controlled by Rizbollo and Name 3 which were acquired for common shares of Acquisitionco. As part of the Arrangement, Acquisitionco and BPLI have amalgamated to form an amalgamated corporation which will carry on business as BPLI Holdings Inc.
Largo Resources Announces Approval for Listing on the Nasdaq Under the Symbol 'LGO"
TORONTO — Largo Resources Ltd. (“ Largo ” or the “ Company “) (TSX: LGO) (OTCQX: LGORF) is pleased to announce that the Company has received approval from The Nasdaq Stock Market LLC (the “ Nasdaq “) to list its issued and outstanding common shares (“ Common Shares “) on the Nasdaq.
AVEO Announces Appointment of Kevin Cullen, M.D., to Its Board of Directors
BOSTON — AVEO Oncology (Nasdaq: AVEO), a commercial and clinical development stage biopharmaceutical company, today announced the appointment of Kevin J. Cullen, M.D., to the Company’s Board of Directors. A widely recognized clinical oncologist with a specialty in head and neck cancer, Dr. Cullen is the Marlene and Stewart Greenebaum Distinguished Professor in Oncology and director of the Program in Oncology at the University of Maryland School of Medicine. He also serves as director of the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center.
weather (High River)
Nextech AR Solutions Corp. Reports Strong Fourth Quarter 2020 Results
VANCOUVER, British Columbia — Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29) announces its financial and operating results for the fourth quarter and year ended December 31, 2020. This press release contains forward-looking statements. Please refer to our cautionary language on forward-looking statements and the other matters set forth at the end of this press release and the beginning of the Management’s Discussion and Analysis (the “MD&A”) for the year ended December 31, 2020. Nextech’s audited financial statements for the year ended December 31, 2020 and notes thereto (the “financial statements”), and the MD&A are available on our website at www.Nextechar.com and are filed on SEDAR at www.sedar.com . All figures are prepared in accordance with International Financial Reporting Standards (IFRS) unless otherwise indicated.
BWX Technologies to Webcast Discussion of its First Quarter 2021 Results on Tuesday, May 4
LYNCHBURG, Va. — BWX Technologies, Inc. (BWXT) (NYSE: BWXT) will webcast a discussion of its first quarter 2021 results on Tuesday, May 4, 2021, at 9:00 a.m. EDT. The company will issue a press release detailing the results after market close on Monday, May 3.